AbCellera Biologics Inc. ABCL Accrued Liabilities & Other
Accrued Liabilities & Other at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s accrued liabilities & other.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s accrued liabilities & other?
- AbCellera Biologics Inc. (ABCL) reported accrued liabilities & other of $39.55M in Q1 2026.
- How has AbCellera Biologics Inc.'s accrued liabilities & other changed year-over-year?
- AbCellera Biologics Inc.'s accrued liabilities & other decreased by 17.3% year-over-year, from $47.84M to $39.55M.
- What is the long-term trend for AbCellera Biologics Inc.'s accrued liabilities & other?
- Over 3 years (2022 to 2025), AbCellera Biologics Inc.'s accrued liabilities & other has grown at a -1.1% compound annual growth rate (CAGR), from $52.5M to $50.78M.
- What does accrued liabilities & other mean?
- Combined accrued expenses and miscellaneous current liabilities not classified in specific categories.